Back to top
more

Cytosorbents (CTSO)

(Delayed Data from NSDQ)

$0.89 USD

0.89
14,680

0.00 (0.24%)

Updated Jun 7, 2024 04:00 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.08%
2Buy17.91%
3Hold9.44%
4Sell5.10%
5Strong Sell2.55%
S&P50011.04%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 36% (89 out of 248)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Brokerage Reports

0 items in cart

Cytosorbents Corporation [CTSO]

Reports for Purchase

Showing records 141 - 160 ( 184 total )

Company: Cytosorbents Corporation

Industry: Medical - Products

Record: 141

01/13/2016

Company Report

Pages: 7

4Q15 Update Largely In Line With Our Estimates

Provider: Merriman Curhan Ford & Co.

Analyst: D SILVA A

Price: 25.00

Research Provided by a Third Party

Company: Cytosorbents Corporation

Industry: Medical - Products

Record: 142

12/01/2015

Company Report

Pages: 5

Price: 24.95

Company: Cytosorbents Corporation

Industry: Medical - Products

Record: 143

11/17/2015

Company Report

Pages: 9

Price: 24.95

Company: Cytosorbents Corporation

Industry: Medical - Products

Record: 144

11/16/2015

Company Report

Pages: 8

Reports 3Q15 Results; Maintaining BUY Rating - $18.75 PT

Provider: Merriman Curhan Ford & Co.

Analyst: D SILVA A

Price: 25.00

Research Provided by a Third Party

Company: Cytosorbents Corporation

Industry: Medical - Products

Record: 145

11/16/2015

Company Report

Pages: 6

REFRESH Study Begins Enrollment; Reiterate Buy

Provider: H.C. Wainwright & Co., Inc.

Analyst: RAMAKANTH S

Price: 25.00

Research Provided by a Third Party

Company: Cytosorbents Corporation

Industry: Medical - Products

Record: 146

10/27/2015

Company Report

Pages: 6

Price: 24.95

Company: Cytosorbents Corporation

Industry: Medical - Products

Record: 147

10/07/2015

Company Report

Pages: 7

Positive Data From User Meeting Provides Added Confidence In Upcoming U.S. REFRESH Trial

Provider: Merriman Curhan Ford & Co.

Analyst: D SILVA A

Price: 25.00

Research Provided by a Third Party

Company: Cytosorbents Corporation

Industry: Medical - Products

Record: 148

10/06/2015

Company Report

Pages: 5

Price: 24.95

Company: Cytosorbents Corporation

Industry: Medical - Products

Record: 149

08/17/2015

Company Report

Pages: 5

Refreshing Sales and Clinical Study; Reiterate Buy

Provider: H.C. Wainwright & Co., Inc.

Analyst: RAMAKANTH S

Price: 10.00

Research Provided by a Third Party

Company: Cytosorbents Corporation

Industry: Medical - Products

Record: 150

08/17/2015

Company Report

Pages: 8

Price: 24.95

Company: Cytosorbents Corporation

Industry: Medical - Products

Record: 151

08/14/2015

Company Report

Pages: 7

Reports 2Q15 Results; Maintaining BUY Rating

Provider: Merriman Curhan Ford & Co.

Analyst: D SILVA A

Price: 25.00

Research Provided by a Third Party

Company: Cytosorbents Corporation

Industry: Medical - Products

Record: 152

07/28/2015

Company Report

Pages: 7

Near Term Focus Should Be On Efficacy - Milestones That Could Result In A SoC Being Established

Provider: Merriman Curhan Ford & Co.

Analyst: D SILVA A

Price: 25.00

Research Provided by a Third Party

Company: Cytosorbents Corporation

Industry: Medical - Products

Record: 153

05/26/2015

Industry Report

Pages: 26

Playing Games with Russell; Annual Index Manipulations May Create Opportunities

Provider: H.C. WAINWRIGHT & CO., INC.

Analyst: DEDE K

Price: 75.00

Research Provided by a Third Party

Company: Cytosorbents Corporation

Industry: Medical - Products

Record: 154

05/20/2015

Company Report

Pages: 8

Price: 24.95

Company: Cytosorbents Corporation

Industry: Medical - Products

Record: 155

05/14/2015

Company Report

Pages: 8

Price: 24.95

Company: Cytosorbents Corporation

Industry: Medical - Products

Record: 156

05/13/2015

Company Report

Pages: 8

Price: 24.95

Company: Cytosorbents Corporation

Industry: Medical - Products

Record: 157

05/12/2015

Company Report

Pages: 7

Reports 1Q15 Results; Maintaining BUY Rating - $18.75 PT

Provider: Merriman Curhan Ford & Co.

Analyst: D SILVA A

Price: 25.00

Research Provided by a Third Party

Company: Cytosorbents Corporation

Industry: Medical - Products

Record: 158

05/12/2015

Company Report

Pages: 5

Sales Force Restructuring and REFRESH Study on Track; Reiterate Buy

Provider: H.C. WAINWRIGHT & CO., INC.

Analyst: RAMAKANTH S

Price: 10.00

Research Provided by a Third Party

Company: Cytosorbents Corporation

Industry: Medical - Products

Record: 159

04/06/2015

Company Report

Pages: 7

Price: 24.95

Company: Cytosorbents Corporation

Industry: Medical - Products

Record: 160

04/02/2015

Company Report

Pages: 5

Short-Term Sacrifice to Aid Long-Term Growth; New $11.50 Price Target; Reiterate Buy

Provider: H.C. WAINWRIGHT & CO., INC.

Analyst: RAMAKANTH S

Price: 10.00

Research Provided by a Third Party